Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Medical help-seeking intentions among patients with early Alzheimer's disease.
Villarejo-Galende A, García-Arcelay E, Piñol-Ripoll G, Del Olmo-Rodríguez A, Viñuela F, Boada M, Franco-Macías E, Ibañez de la Peña A, Riverol M, Puig-Pijoan A, Abizanda-Soler P, Arroyo R, Baquero-Toledo M, Feria-Vilar I, Balasa M, Berbel Á, Rodríguez-Rodríguez E, Vieira-Campos A, Garcia-Ribas G, Rodrigo-Herrero S, Lleó A, Maurino J. Villarejo-Galende A, et al. Among authors: baquero toledo m. Front Psychiatry. 2023 Dec 19;14:1290002. doi: 10.3389/fpsyt.2023.1290002. eCollection 2023. Front Psychiatry. 2023. PMID: 38173708 Free PMC article.
Awareness of Diagnosis in Persons with Early-Stage Alzheimer's Disease: An Observational Study in Spain.
Villarejo-Galende A, García-Arcelay E, Piñol-Ripoll G, Del Olmo-Rodríguez A, Viñuela F, Boada M, Franco-Macías E, de la Peña AI, Riverol M, Puig-Pijoan A, Abizanda-Soler P, Arroyo R, Baquero-Toledo M, Feria-Vilar I, Balasa M, Berbel Á, Rodríguez-Rodríguez E, Vieira-Campos A, García-Ribas G, Rodrigo-Herrero S, Lleó A, Maurino J. Villarejo-Galende A, et al. Among authors: baquero toledo m. Neurol Ther. 2022 Sep;11(3):1183-1192. doi: 10.1007/s40120-022-00367-3. Epub 2022 Jun 1. Neurol Ther. 2022. PMID: 35648383 Free PMC article.
Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial.
Teng E, Manser PT, Pickthorn K, Brunstein F, Blendstrup M, Sanabria Bohorquez S, Wildsmith KR, Toth B, Dolton M, Ramakrishnan V, Bobbala A, Sikkes SAM, Ward M, Fuji RN, Kerchner GA; Tauriel Investigators. Teng E, et al. JAMA Neurol. 2022 Aug 1;79(8):758-767. doi: 10.1001/jamaneurol.2022.1375. JAMA Neurol. 2022. PMID: 35696185 Free PMC article. Clinical Trial.
Quality of Life and the Experience of Living with Early-Stage Alzheimer's Disease.
Villarejo-Galende A, García-Arcelay E, Piñol-Ripoll G, Del Olmo-Rodríguez A, Viñuela F, Boada M, Franco-Macías E, Ibañez de la Peña A, Riverol M, Puig-Pijoan A, Abizanda-Soler P, Arroyo R, Baquero-Toledo M, Feria-Vilar I, Balasa M, Berbel Á, Rodríguez-Rodríguez E, Vieira-Campos A, García-Ribas G, Rodrigo-Herrero S, Terrancle Á, Prefasi D, Lleó A, Maurino J. Villarejo-Galende A, et al. Among authors: baquero toledo m. J Alzheimers Dis. 2022;90(2):719-726. doi: 10.3233/JAD-220696. J Alzheimers Dis. 2022. PMID: 36155523 Free PMC article.
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.
Prognostic value of cerebrospinal fluid biomarkers in mild cognitive impairment due to Alzheimer disease.
López-Cuevas R, Baquero-Toledo M, Cuevas-Jiménez A, Martín-Ibáñez N, Pascual-Costa R, Moreno-Monedero MJ, Cañada-Martínez A, Peña-Bautista C, Ferrer-Cairols I, Álvarez-Sánchez L, Cháfer-Pericás C. López-Cuevas R, et al. Among authors: baquero toledo m. Neurologia (Engl Ed). 2023 May;38(4):262-269. doi: 10.1016/j.nrleng.2020.07.024. Epub 2023 Apr 7. Neurologia (Engl Ed). 2023. PMID: 37031800 Free article.
Prognostic value of cerebrospinal fluid biomarkers in mild cognitive impairment due to Alzheimer disease.
López-Cuevas R, Baquero-Toledo M, Cuevas-Jiménez A, Martín-Ibáñez N, Pascual-Costa R, Moreno-Monedero MJ, Cañada-Martínez A, Peña-Bautista C, Ferrer-Cairols I, Álvarez-Sánchez L, Cháfer-Pericás C. López-Cuevas R, et al. Neurologia (Engl Ed). 2020 Oct 31:S0213-4853(20)30292-9. doi: 10.1016/j.nrl.2020.07.026. Online ahead of print. Neurologia (Engl Ed). 2020. PMID: 33143865 Free article. English, Spanish.
Artificial Intelligence on FDG PET Images Identifies Mild Cognitive Impairment Patients with Neurodegenerative Disease.
Prats-Climent J, Gandia-Ferrero MT, Torres-Espallardo I, Álvarez-Sanchez L, Martínez-Sanchis B, Cháfer-Pericás C, Gómez-Rico I, Cerdá-Alberich L, Aparici-Robles F, Baquero-Toledo M, Rodríguez-Álvarez MJ, Martí-Bonmatí L. Prats-Climent J, et al. Among authors: baquero toledo m. J Med Syst. 2022 Jun 17;46(8):52. doi: 10.1007/s10916-022-01836-w. J Med Syst. 2022. PMID: 35713815 Free article.
Relationship between neuroimaging and emotion recognition in mild cognitive impairment patients.
Gandia-Ferrero MT, Adrián-Ventura J, Cháfer-Pericás C, Alvarez-Sanchez L, Ferrer-Cairols I, Martinez-Sanchis B, Torres-Espallardo I, Baquero-Toledo M, Marti-Bonmati L. Gandia-Ferrero MT, et al. Among authors: baquero toledo m. Behav Brain Res. 2024 Mar 12;461:114844. doi: 10.1016/j.bbr.2023.114844. Epub 2024 Jan 2. Behav Brain Res. 2024. PMID: 38176615
15 results